Dashboard
Manage Tickers

TCBP TC BioPharm (Holdings) Ltd


nm (nm)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ na
-- x --
-- x --
-- - --
nm - nm
0
na
na
nm
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
03/21/2025 21:05:50

why-tc-biopharm-tcbp-stock-is-down-over-60-today
Why TC Biopharm (TCBP) Stock Is Down Over ...
03/21/2025 17:49:02

TC Biopharm shares are trading lower by 64% during Friday's session. The company announced the transition from Nasdaq to OT...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
03/21/2025 17:05:38

tc-biopharm-shares-resume-trade
TC BioPharm Shares Resume Trade
03/21/2025 14:56:19

tc-biopharm-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down--221
TC BioPharm Shares Halted On Circuit Break...
03/21/2025 14:47:26

tcbp-announces-its-securities-will-be-suspended-for-trading-on-nasdaq-effective-at-the-opening-of-trading-on-monday-march-24-2025
TCBP Announces Its Securities Will Be Susp...
03/21/2025 14:46:36

TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company"), (NASDAQ:TCBP) a clinical-stage biotechnology compa...

tc-biopharm-announces-outsourcing-initiatives-to-reduce-burn-rate-and-overhead
TC BioPharm Announces Outsourcing Initiati...
03/18/2025 12:13:34

The company is expected to reduce core operational burn by 55% when compared to 2024

tcbp-announces-non-binding-letter-of-intent-to-acquire-ophthalmic-pharmaceutical-company-to-acquire-100-of-company
TCBP Announces Non-Binding Letter Of Inten...
03/05/2025 13:34:34

tc-biopharm-shares-are-trading-higher-after-completing-cohort-a-in-its-achieve-phase-2b-clinical-trial
TC Biopharm shares are trading higher afte...
02/13/2025 13:32:17

tcbp-completes-cohort-a-in-achieve-phase-2b-clinical-trial
TCBP Completes Cohort A In ACHIEVE Phase 2...
02/13/2025 13:32:04

tc-biopharma-ads-ratio-change-same-effect-as-1-for-20-reverse-stock-split
TC BioPharma ADS Ratio Change Same Effect ...
02/05/2025 17:03:23

tc-biopharm-changes-ratio-of-adss-from-1-ads-representing-200-ordinary-shares-to-1-ads-representing-4000-ordinary-shares
TC BioPharm Changes Ratio Of ADSs From 1 A...
02/05/2025 17:01:23

tcbp-announces-that-it-intends-to-begin-proof-of-concept-preclinical-studies-for-its-lead-therapeutic-tcb008-for-treatment-in-h5n1-commonly-known-as-bird-flu
TCBP Announces That It Intends To Begin Pr...
01/15/2025 13:33:24

TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ:TCBP) a clinical-stage biotechnology compan...

tc-biopharma-continues-trading-on-nasdaq
TC BioPharma Continues Trading On Nasdaq
01/06/2025 18:32:10

tc-biopharm-announced-it-has-advanced-negotiations-with-both-of-its-previously-aforementioned-acquisition-candidates-the-company-will-be-focusing-its-acquisition-efforts-on-two-main-areas-natural-kill-cell-technologies-and-car-related-technologies
TC Biopharm Announced It Has Advanced Nego...
12/31/2024 15:16:52

tc-biopharm-says-025-dividend-formally-approved-by-shareholders
TC BioPharm Says $0.25 Dividend Formally A...
12/30/2024 15:33:02

tc-biopharm-completes-full-dose-regimen-in-achieve-phase-2b-clinical-trial
TC BioPharm Completes Full-Dose Regimen In...
12/20/2024 13:37:08

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
12/18/2024 21:06:25

hc-wainwright--co-maintains-buy-on-tc-biopharm-holdings-lowers-price-target-to-3
HC Wainwright & Co. Maintains Buy on TC Bi...
12/06/2024 11:16:40

HC Wainwright & Co. analyst Mitchell Kapoor maintains TC BioPharm (Holdings) (NASDAQ:TCBP) with a Buy and lowers the pri...

tcbp-provides-quarterly-update-on-achieve-uk-clinical-trial-company-intends-to-use-cohort-a-patient-data-to-justify-further-increases-in-tcb008-dose
TCBP Provides Quarterly Update On ACHIEVE ...
12/04/2024 13:35:13

Positive safety data, allowing for exploration of higher TCB008 doses4 UK-based clinical sites recruiting patients, with a furt...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION